- $31.73m
- $72.46m
- $26.55m
U.S. STOCKS ON THE MOVE-Kraft Heinz Co, Coinbase, Altria Group
U.S. STOCKS ON THE MOVE-Athira Pharma, U.S. Well Services, Revlon
U.S. STOCKS ON THE MOVE-Dow, Boeing, Revlon, U.S. Well Services
Wainwright starts Celularity with 'buy' on placenta-derived therapy potential
Brief: Celularity To Be Added To The Russell 3000 Index And The Small-Cap Russell 2000
Brief: Celularity Appoints Industry Leader Diane Parks To Its Board Of Directors
Brief: Celularity Inc Files For Offering Of Up To 8.11 Million Shares Of Class A Common Stock By The Selling Securityholder
Brief: Celularity Reports Q1 2022 Financial Results And Provides Corporate Update
Brief: Celularity Inc Files Preliminary Prospectus Related To Offering Of 10.5 Million Units - SEC Filing
Brief: Celularity - On April 29 Received E-Mail Notification From FDA Regarding Cycart-19 Ind - Filing
Brief: Celularity Offering 6.3 Mln Shares Of Class A Common Stock
Truist cuts Celularity to 'hold' on likely cash crunch
Brief: Celularity Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Update
Brief: Celularity Receives Orphan Drug Designation From U.S. FDA For Its NK Cell Therapy CYNK-101
U.S. RESEARCH ROUNDUP-Chargepoint Holdings, Ollie'S Bargain Outlet Holdings, Williams-Sonoma
Brief: Celularity Receives Fast Track Tag From U.S. FDA For Cell Therapy Candidate Cynk-101 For Advanced Her2/Neu Positive Gastric And Gastroesophageal Junction Cancers
U.S. STOCKS ON THE MOVE-regular hours
U.S. STOCKS ON THE MOVE-GoDaddy, Nvidia, travel stocks
Celularity jumps after cancer drug gets FDA's Fast Track tag